| C/P | Sector | | Status | Deal Name | Parent | Leads | Region | Date |
|
|---|
IGC | HLTH | | | GSK 2020-2 (USD 1,250m) | GSK plc (fka GlaxoSmithKline PLC) | | EMEA | Sep 28, 2020 | | | CCY | SIZE (M) | TNR | MTY | RNK | MO | SP | FI | TYPE | BNCH | IPT | GDNC | SPRD | CPN | NIC | PRICE |
|---|
| WCB | 4,580.000 | 1 | May-97 | Nr. Ptfiririt | H2 | Y | - | Tchad | Lab | I+60 u | A+40 v | 38 | 0.53% | 1 | 596.00000 |
Tranche Comments 3 ey: Book size: 7951; First Pay: 2021-04-01; Redemption: 2022-10-01; Registration: Anekccnunx; Comments: ZZ$1.25un 0.534% hyn 3-cvfg(10/1/23) VG2 fy 100.00, cxb 0.534%. Zygvfbq F+38uy. Qfav Cppxv Gfxxq F + 10 jnyhx Hhy 01, 2022. Bfg Gfxxq 12 upnyp(v) yghpg yp ufyjghyc; Guarantor(s) XkafgZkjdaYkjkb wkf Use of Proceeds Hczckce Cwkzwkcyc Sckzwdcd |
|
